ATP gatekeeper of Plasmodium protein kinase may provide the opportunity to develop selective antimalarial drugs with multiple targets
Malaria is one of the most devastating infectious diseases that caused millions of clinical cases annually despite decades of prevention efforts. Recent cases of Plasmodium falciparum resistance against the only remaining class of effective antimalarial (artemisinin) in South East Asia may soon pose...
Main Authors: | Fauze Mahmud, Lee, Ping Chin, Wahab, H., Mustaffa, K.F., Leow, C.H., Rasul, A., Lai, N.S. |
---|---|
Format: | Article |
Language: | English |
Published: |
2020
|
Subjects: | |
Online Access: | https://eprints.ums.edu.my/id/eprint/26332/1/ATP%20gatekeeper%20of%20Plasmodium%20protein%20kinase%20may%20provide%20the%20opportunity%20to%20develop%20selective%20antimalarial%20drugs%20with%20multiple%20targets.pdf |
Similar Items
-
Plasmodium falciparum protein kinase as a potential therapeutic target for antimalarial drugs development
by: Fauze Mahmud, et al.
Published: (2020) -
Identification Of Antimalarial Compounds And Their Mode Of Actions
by: Mahmud, Fauze
Published: (2022) -
Unravelling structure activity relationship between an antimalarial compound and plasmodium falciparum protein kinase 6
by: Yew, Wei Ni
Published: (2023) -
Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
by: Barnes, K, et al.
Published: (2005) -
The antimalarial agent mefloquine inhibits ATP-sensitive K-channels.
by: Gribble, F, et al.
Published: (2000)